MTS2 gene


Ontology type: sgo:Patent     


Patent Info

DATE

2001-01-30T00:00

AUTHORS

Alexander Kamb

ABSTRACT

The present invention relates to somatic mutations in the Multiple Tumor Suppressor (MTS) gene in human cancers and their use in the diagnosis and prognosis of human cancer. The invention further relates to germ line mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Alexander Kamb", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/366704a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015821919", 
          "https://doi.org/10.1038/366704a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gad.8.24.2939", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038530556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0994-22", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042277853", 
          "https://doi.org/10.1038/ng0994-22"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/371257a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045553304", 
          "https://doi.org/10.1038/371257a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0994-27", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046920232", 
          "https://doi.org/10.1038/ng0994-27"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.8153634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062652972"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-01-30T00:00", 
    "description": "

The present invention relates to somatic mutations in the Multiple Tumor Suppressor (MTS) gene in human cancers and their use in the diagnosis and prognosis of human cancer. The invention further relates to germ line mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.

", "id": "sg:patent.US-6180776-B1", "keywords": [ "gene", "invention", "somatic mutation", "tumor suppressor", "human cancer", "diagnosis", "prognosis", "Germ-Line Mutation", "tumor suppressor gene", "predisposition", "melanoma", "leukemia", "Astrocytoma", "Glioblastoma", "lymphoma", "glioma", "Hodgkin's", "CLL", "Neoplasm", "pancreas", "breast", "Thyroid Gland", "ovary", "uterus", "testis", "kidney", "stomach", "rectum", "therapy", "mutation", "Genetic Therapy", "replacement therapy", "protein", "Mass Screening", "drug", "cancer therapy" ], "name": "MTS2 gene", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.420032.7", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.223827.e", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-6180776-B1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:27", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_03086.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-6180776-B1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-6180776-B1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-6180776-B1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-6180776-B1'


 

This table displays all metadata directly associated to this object as RDF triples.

82 TRIPLES      15 PREDICATES      57 URIs      44 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-6180776-B1 schema:about anzsrc-for:3142
2 schema:author N83a7f09e18164109b673f6d4b372cf5b
3 schema:citation sg:pub.10.1038/366704a0
4 sg:pub.10.1038/371257a0
5 sg:pub.10.1038/ng0994-22
6 sg:pub.10.1038/ng0994-27
7 https://doi.org/10.1101/gad.8.24.2939
8 https://doi.org/10.1126/science.8153634
9 schema:datePublished 2001-01-30T00:00
10 schema:description <p>The present invention relates to somatic mutations in the Multiple Tumor Suppressor (MTS) gene in human cancers and their use in the diagnosis and prognosis of human cancer. The invention further relates to germ line mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.</p>
11 schema:keywords Astrocytoma
12 CLL
13 Genetic Therapy
14 Germ-Line Mutation
15 Glioblastoma
16 Hodgkin's
17 Mass Screening
18 Neoplasm
19 Thyroid Gland
20 breast
21 cancer therapy
22 diagnosis
23 drug
24 gene
25 glioma
26 human cancer
27 invention
28 kidney
29 leukemia
30 lymphoma
31 melanoma
32 mutation
33 ovary
34 pancreas
35 predisposition
36 prognosis
37 protein
38 rectum
39 replacement therapy
40 somatic mutation
41 stomach
42 testis
43 therapy
44 tumor suppressor
45 tumor suppressor gene
46 uterus
47 schema:name MTS2 gene
48 schema:recipient https://www.grid.ac/institutes/grid.223827.e
49 https://www.grid.ac/institutes/grid.420032.7
50 schema:sameAs https://app.dimensions.ai/details/patent/US-6180776-B1
51 schema:sdDatePublished 2019-04-18T10:27
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher Ne004fb980dec4d00a7fe2596c43c3194
54 sgo:license sg:explorer/license/
55 sgo:sdDataset patents
56 rdf:type sgo:Patent
57 N83a7f09e18164109b673f6d4b372cf5b rdf:first Nf2637d7f1bb84ee7b50fdd192eea1daa
58 rdf:rest rdf:nil
59 Ne004fb980dec4d00a7fe2596c43c3194 schema:name Springer Nature - SN SciGraph project
60 rdf:type schema:Organization
61 Nf2637d7f1bb84ee7b50fdd192eea1daa schema:name Alexander Kamb
62 rdf:type schema:Person
63 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
64 rdf:type schema:DefinedTerm
65 sg:pub.10.1038/366704a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015821919
66 https://doi.org/10.1038/366704a0
67 rdf:type schema:CreativeWork
68 sg:pub.10.1038/371257a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045553304
69 https://doi.org/10.1038/371257a0
70 rdf:type schema:CreativeWork
71 sg:pub.10.1038/ng0994-22 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042277853
72 https://doi.org/10.1038/ng0994-22
73 rdf:type schema:CreativeWork
74 sg:pub.10.1038/ng0994-27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046920232
75 https://doi.org/10.1038/ng0994-27
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1101/gad.8.24.2939 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038530556
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1126/science.8153634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062652972
80 rdf:type schema:CreativeWork
81 https://www.grid.ac/institutes/grid.223827.e schema:Organization
82 https://www.grid.ac/institutes/grid.420032.7 schema:Organization
 




Preview window. Press ESC to close (or click here)


...